Author
Lilach O. Lerman
- Indexed works
- 11
- Total citations
- 2,979
- Active years
- 6
Collaborators
Works in the record
EBioMedicine 2019
Open access · CC-BY
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
Nature Reviews Nephrology 2022
Open access · OA
Cellular senescence: the good, the bad and the unknown
Frontiers in Cell and Developmental Biology 2020
Open access · CC-BY
Human Obesity Induces Dysfunction and Early Senescence in Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells
Journal of the American Society of Nephrology 2021
Preprint · OA
Progressive Cellular Senescence Mediates Renal Dysfunction in Ischemic Nephropathy
EBioMedicine 2020
Open access · CC-BY
Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456
Oxidative Medicine and Cellular Longevity 2021
Open access · CC-BY
Quercetin Reverses Cardiac Systolic Dysfunction in Mice Fed with a High‐Fat Diet: Role of Angiogenesis
Frontiers in Endocrinology 2021
Open access · CC-BY
Metabolic Syndrome Is Associated With Altered mRNA and miRNA Content in Human Circulating Extracellular Vesicles
EBioMedicine 2026
Open access · CC-BY
Senolytics, dasatanib plus quercetin, reduce kidney inflammation, senescent cell abundance, and injury while restoring geroprotective factors in murine diabetic kidney disease
Stem Cells 2023
Open access · OA
Mesenchymal Stem/Stromal Cells Therapy for Metabolic Syndrome: Potential Clinical Application?
Kidney International 2026
Open access · CC-BY
Targeting cellular senescence in diabetic kidney disease: potential of regenerative, cell-based therapies and other senotherapeutic approaches
Journal of the American Society of Nephrology 2022
Citation only